Lewis, G. D., Garcia-Pavia, P., Masri, A., Merkely, B., Nassif, M. E., Peña-Peña, M. L., Barriales-Villa, R., Bilen, O., Burroughs, M., Claggett, B., Costabel, J. P., de Barros Correia, E., Dybro, A. M., Kulac, I. J., Lakdawala, N. K., Mann, A., Maron, M. S., McGinnis, S., Nair, A., ... MAPLE-HCM Investigators (2026). Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy The MAPLE-HCM Randomized Clinical Trial. JAMA Cardiology. Advance online publication. https://doi.org/10.1001/jamacardio.2026.1730

Venner, M. F. G. H. M., Verdonschot, J. A. J., & Knackstedt, C. (2026). Letter to the editor: Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 442, Article 133886. https://doi.org/10.1016/j.ijcard.2025.133886

Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429

Gilani, K., Wei, W., Peters, C., Verket, M., Brunner-La Rocca, H.-P., Nicolis, E., Colombo, M., Marx-Schutt, K., Urovi, V., & Dumontier, M. (2026). CMEO: a metadata-centric ontology for clinical studies exploration and harmonization assessment. BMC Medical Informatics and Decision Making, 26(1), Article 8. https://doi.org/10.1186/s12911-025-03272-5

Herrmann, J. J., Van Berlo, R., Brunner-La Rocca, H.-P., Sanders-Van Wijk, S., Gommans, D. H. F., & Van Kimmenade, R. R. J. (2026). Fluid restriction in patients with heart failure: a systematic review. Heart. Advance online publication. https://doi.org/10.1136/heartjnl-2025-326784

van de Bovenkamp, A. A., Nassiri, S., de Man, F. S., Oosterveer, F. P. T., Mourmans, S. G. J., van Raalte, D. H., Dijkmans, P. A., van Heerebeek, L., van Empel, V. P. M., Eringa, E. C., Bakermans, A. J., & Handoko, M. L. (2026). Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomized clinical trial. European journal of heart failure. Advance online publication. https://doi.org/10.1093/ejhf/xuag162

Johnson, R., Fletcher, R. A., Peters, S., Ohanian, M., Soka, M., Smolnikov, A., Abihider, K. E., Ackerman, M. J., Ader, F., Akhtar, M. M., Amin, A. S., Ashley, E. A., Atherton, J. J., Austin, R., Baas, A. F., Bagnall, R. D., Ross, S. B., Blouin, J.-L., Brown, E. E., ... Australian Genomics Cardiac Flagship (2025). Titin-related familial dilated cardiomyopathy: factors associated with disease onset. European Heart Journal, 46(48), 5240-5257. https://doi.org/10.1093/eurheartj/ehaf380

Steiner, B., Neumann, A., Schwertfeger, M., Verket, M., Romero, I., Hurtado, C., Schiefel, V., McNulty, A., Sankarpandi, S., Gingele, A. J., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Patient-reported outcome and experience measures in cardiovascular disease: a scoping review as part of iCARE4CVD. Journal of patient-reported outcomes, 9(1), Article 141. https://doi.org/10.1186/s41687-025-00980-4

Faassen, I. M. E., Heijligers, M., Weijermans, N. H. N., van Buul-van Zwet, M. L., Zietse, C. S., Zamani Esteki, M., Paulussen, A. D. C., & Verdonschot, J. A. J. (2025). Preimplantation genetic testing for cardiomyopathies: a case series illustrating the clinical and technological perspective. European Heart Journal - Case Reports, 9(12), Article ytaf630. https://doi.org/10.1093/ehjcr/ytaf630

Mostert, D., Ferron, S., Olmeda, C. V., Rampazzo, A., & Calore, M. (2025). Advances in arrhythmogenic cardiomyopathy modeling using human-induced pluripotent stem cell-based models. Heart Rhythm, 22(12), e1286-e1299. https://doi.org/10.1016/j.hrthm.2025.08.012

Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure, 27(12), 2897-2902. https://doi.org/10.1002/ejhf.3651

Hoes, M. F., Wang, S., & Luiken, J. J. F. P. (2025). Endosomal Mechanisms in Heart Failure Pathophysiology. Current Heart Failure Reports, 22(1), Article 38. https://doi.org/10.1007/s11897-025-00728-7

Gingele, A. J., Eurlings, C., Boyne, J. J., & Brunner-La Rocca, H.-P. (2025). Identifying patients' signs and symptoms to guide eHealth-directed diuretic therapy intensification in heart failure-Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Wiener Klinische Wochenschrift, 137(23-24), 774-777. https://doi.org/10.1007/s00508-025-02551-5

Stroeks, S. L. V. M., Wang, P., Merlo, M., Muller, S., Paldino, A., Mora-Ayestaran, N., Jason, M., Ferro, M. D., Loca, C. P., Dominguez, F., Gonzalez-Lopez, E., van den Wijngaard, A., Venner, M. F. G. H. M., Sikking, M., Minten, M., Nihant, B., Beelen, N., Graw, S., Medo, K., ... Verdonschot, J. A. J. (2025). Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy. European journal of heart failure, 27(12), 3205-3218. https://doi.org/10.1002/ejhf.70040

Malgie, J., Wilde, M. I., Koudstaal, S., Denham, R., da Fonseca, C. A., Swart, H. P., van Ofwegen, C. E. E., Yilmaz, A., Pisters, R., Linssen, G. C. M., Faber, N., van Heerebeek, L., van de Swaluw, J. E. C., de Boer, R. A., Brunner-La Rocca, H.-P., & Brugts, J. J. (2025). Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF. European journal of heart failure, 27(12), 2735-2746. https://doi.org/10.1002/ejhf.70006

Li, X., Achten, A., Nassiri, S., Mourmans, S., van de Bovenkamp, A. A., Knackstedt, C., Handoko, M. L., Weerts, J., & van Empel, V. (2025). Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohorts. Netherlands Heart Journal, 33(12), 412-420. https://doi.org/10.1007/s12471-025-02000-y

Achten, A., Peeters, L., Verkoulen, G., Weerts, J., Knackstedt, C., Boerma, E.-J., van Empel, V., & Wijk, S. S. (2025). Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity. Heart Failure Reviews, 30(6), 1207-1213. https://doi.org/10.1007/s10741-025-10540-z

Verdonschot, J. A. J., Kaski, J. P., Asselbergs, F. W., Behr, E. R., Charron, P., Dawson, D., Haugaa, K. H., Kuchynka, P., Lopes, L. R., Mazzanti, A., Monserrat, L., Pantazis, A., Prasad, S. K., Schunkert, H., Seferovic, P. M., Sheppard, M. N., Sinagra, G., van Tintelen, J. P., Tome Esteban, M. T., ... Garcia-Pavia, P. (2025). Clinical care of family members of patients with dilated cardiomyopathy: A clinical consensus statement of the Heart Failure Association of the European Society of Cardiology, the European Society of Cardiology Working Group on Myocardial & Pericardial Diseases, and the European Society of Cardiology Council on Cardiovascular Genomics. European Heart Journal, 46(43), 4569-4582. Article ehaf571. https://doi.org/10.1093/eurheartj/ehaf571

Lagrange, J., Jahangiri, M., Baudry, G., Monzo, L., Guerci, P., ter Maaten, J. M., Heymans, S., Mercier, N., & Girerd, N. (2025). Updates on the endothelial glycocalyx in heart failure with preserved ejection fraction. American Journal of Physiology-heart and Circulatory Physiology, 329(5), H1316-H1330. https://doi.org/10.1152/ajpheart.00410.2025

Bolaji, M. D., Hartmann, P. E., Buhl, E. M., Colpaert, R. M. W., Gasparella, F., de Windt, L. J., Calore, M., Leube, R. E., & Moazzen, H. (2025). Epicardial Abnormalities and Mesenchymal/Hematopoietic Cell Expansion in Plakophilin 2-Null Mouse Embryonic Hearts. Cells, 14(22), Article 1751. https://doi.org/10.3390/cells14221751

Heuvelmans, L., Mostert, D., Spano, G., Stoll, M., & De Windt, L. J. (2025). GATA4: orchestrating cardiac development and beyond. Cardiovascular Research, 121(16), 2476-2483. https://doi.org/10.1093/cvr/cvaf230

Mayen, A.-L., Maasen, K., Hana, C., Knaze, V., Scheijen, J., Eussen, S. J. P. M., Vangrieken, P., Debras, C., Blanco, J., Dahm, C. C., Aleksandrova, K., Schulze, M. B., Dansero, L., Masala, G., Panico, S., Sieri, S., Guevara, M., Moreno Iribas, C., Petrova, D., ... Jenab, M. (2025). Higher intakes of dietary dicarbonyl compounds are associated with lower risk of cardiovascular disease. European Journal of Preventive Cardiology, 32(16), 1588-1600. Article zwaf060. https://doi.org/10.1093/eurjpc/zwaf060

Smets, L., Viola, M. F., Boesch, M., Raman, J., Van Melkebeke, L., Nobis, M., Flint, E., Pajk, N., Brescia, P., Silvestri, A., Feio-Azevedo, R., Modave, E., De Herdt, L., Sanga, A., Pop, O. T., Govaere, O., Verbeek, J., Denadai-Souza, A., Cassiman, D., ... Van Der Merwe, S. W. (2025). Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis. Gut. Advance online publication. https://doi.org/10.1136/gutjnl-2025-335745

Venner, M. F. G. H. M., Heymans, A. B. M., Beelen, N. J., Stroeks, S. L. V. M., Faassen, I. M. E., Sikking, M. A., Henkens, M. T. H. M., Van Der Crabben, S. N., Raafs, A. G., Heymans, S. R. B., & Verdonschot, J. A. J. (2025). Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathy. EP Europace, 27(11), Article euaf279. https://doi.org/10.1093/europace/euaf279

Stroeks, S. L. V. M., Merlo, M., Mora-Ayestaran, N., Jason, M., Tayal, U., Wang, P., Cannatà, A., Sikking, M. A., Dal Ferro, M., Peiro, B., Willemars, M., Hellebrekers, D. M. E. I., van Leeuwen, R. E. W., Setti, M., Gonzalez-Lopez, E., Krapels, I. P. C., Pio Loco Detto Gava, C., van den Wijngaard, A., Henkens, M. T. H. M., ... Verdonschot, J. A. J. (2025). Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy. Circulation-Heart Failure, 18(11), e012592. Article 012592. https://doi.org/10.1161/CIRCHEARTFAILURE.124.012592

Vencato, S., Cagnin, S., Romanato, C., Murali, K., Velle, A., Sales, G., Romualdi, C., Rakszewska, A., Conrad, C., Facchinello, N., Braghetta, P., Vitiello, L., Rampazzo, A., & Calore, M. (2025). Single nucleus transcriptomic profiling of cardiac cells in a novel transgenic mouse model of arrhythmogenic cardiomyopathy. European Journal of Human Genetics, 33, 682-682.

Vermeulen, C., van Geloven, N., Mertens, B., Spelmink, S. E., Schipperus, M. R., Janssen, M. P., Kerkhoffs, J.-L. H., den Besten, G., van den Bos, A. G., Korver-Keularts, I. M. L. W., van de Kerkhof, D., Klinkspoor, H. J. H., De Vooght, K. M. K., van Gammeren, A. J., Russcher, H., Heijnen, J. W. M., de Korte, D., van Der Meer, P. F., & Klei, T. R. L. (2025). Clinical evaluation of red cell concentrates in non-DEHP plasticized containers compared with standard DEHP plasticized containers: A quasi-randomized observational multicentre study. Vox Sanguinis, 120(11), 1183-1188. https://doi.org/10.1111/vox.70019

Tingen, H. S. A., Berends, M., Tubben, A., van der Meer, P., Slart, R. H. J. A., Bijzet, J., van der Zwaag, P. A., Kimmich, C., Knackstedt, C., Muntinghe, F. L. H., Houwerzijl, E. J., Hazenberg, B. P. C., & Nienhuis, H. L. A. (2025). Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 5000-5005. https://doi.org/10.1007/s00259-025-07328-6

Gigli, M., Verdonschot, J. A. J., Garcia-Pavia, P., Stolfo, D., Monserrat, L., Prasad, S., Mazzanti, A., Asselbergs, F. W., Bauce, B., Charron, P., Dawson, D., Halliday, B. P., Mestroni, L., Seferovic, P., Tayal, U., Esteban, M. T. T., Van Tintelen, P., Heymans, S., Pantazis, A., ... Sinagra, G. (2025). Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC. European journal of heart failure, 27(11), 2229-2243. https://doi.org/10.1002/ejhf.70042

Setti, M., Iseppi, M., Verdonschot, J. A. J., Rizzi, J. G., Paldino, A., Gava, C. P. L. D., Barbati, G., Dal Ferro, M., Venner, M. F. G. H. M., Raafs, A. G., Gigli, M., Stolfo, D., De Luca, A., De Angelis, G., Capovilla, T. M., Graw, S., Ribichini, F. L., Taylor, M., Mestroni, L., ... Merlo, M. (2025). Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy. European journal of heart failure, 27(11), 2571-2581. Article 3671. https://doi.org/10.1002/ejhf.3671

Chua, A. P. A., Weerts, J., Achten, A., Nabeta, T., Sarrazyn, C., Lopez-Santi, P., Mourmans, S. G. J., Su, J. L., Bax, J. J., Knackstedt, C., van Empel, V. P. M., & Ajmone-Marsan, N. (2025). Left Atrial Strain Index in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American Society of Echocardiography, 38(11), 1099-1101. https://doi.org/10.1016/j.echo.2025.07.008

Adamo, M., Pagnesi, M., Chioncel, O., Bayes-Genis, A., Abdelhamid, M., Antohi, E.-L., Bucciarelli-Ducci, C., Chieffo, A., Cosyns, B., Gilard, M., Grapsa, J., Gonzalez, A., Gustafsson, F., Iung, B., Joner, M., Karam, N., Lund, L. H., Maisano, F., Moura, B., ... Metra, M. (2025). Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European journal of heart failure, 27(11), 2623-2633. https://doi.org/10.1002/ejhf.70023

Beverborg, N. G., Alnuwaysir, R. I. S., Markousis-Mavrogenis, G., Hoes, M. F., van Der Wal, H. H., Romaine, S. P. R., Nath, M., Koekoemoer, A., Cleland, J. G. F., Lang, C. C., Anker, S. D., Dickstein, K., Metra, M., Ng, L. L., van Veldhuisen, D. J., Voors, A. A., Samani, N. J., & van Der Meer, P. (2025). The transcriptional profile of iron deficiency in patients with heart failure: Heme-sparing and reduced immune processes. European journal of heart failure, 27(11), 2313-2324. https://doi.org/10.1002/ejhf.3562

Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P. P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J., & Michels, M. (2025). Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression. International Journal of Cardiology, 437, Article 133444. https://doi.org/10.1016/j.ijcard.2025.133444

Heymans, A. B. M., Bianchi, L., Volders, P. G. A., van der Crabben, S. N., & Verdonschot, J. A. J. (2025). SCN5A Cardiomyopathy: from Ion Channel Dysfunction To Clinical Disease. Current Cardiology Reports, 27(1), Article 138. https://doi.org/10.1007/s11886-025-02298-5

Gawalko, M., Habibi, Z., Verhaert, D. V. M., Engels, M., Weerts, J., Adriaans, B., Chaldoupi, S.-M., ter Bekke, R. M. A., Den Uijl, D. W., Luermans, J. G. L. M., Van Empel, V. P. M., Schotten, U., Vernooy, K., & Linz, D. (2025). Discordance between left atrial pressure and risk scores in assessment of heart failure with preserved ejection fraction in patients with atrial fibrillation undergoing catheter ablation. EP Europace, 27(10), Article euaf245. https://doi.org/10.1093/europace/euaf245

Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5

D'Italia, G., Coenen, D. M., Lemmens, T. P., Brandts, L., Wielders, S. J. H., Nagy, M., Mourmans, S. G. J., Achten, A., Al-Abadi, A., Weerts, J., Aizpurua, A. B., van Empel, V., Schroen, B., & Cosemans, J. M. E. M. (2025). Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction. Esc heart failure, 12(5), 3444-3460. https://doi.org/10.1002/ehf2.15361

van Koll, J., Engels, M. D. E. A., Rijks, J. H. J., Salari, M., Luijten, J., Lumens, J., van Empel, V. P. M., Westra, S. W., van Stipdonk, A. M. W., Lankveld, T. A. R., Chaldoupi, S. M., Joza, J., Beukema, R. J., Luermans, J. G. L. M., Linz, D. K., & Vernooy, K. (2025). Long-term outcomes of pace-and-ablate strategy in patients with atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 68(7), 1487-1495. Article 100786. https://doi.org/10.1007/s10840-025-02038-3

Perotto, M., Paldino, A., Mazzarotto, F., Barbati, G., Stroeks, S. L. V. M., Verdonschot, J. A. J., Akhtar, M., Elliott, P., Ochoa, J. P., Garcia-Pavia, P., de Frutos, F., Sepp, R., Hategan, L., Prasad, S., Yazdani, M., Morris-Rosendahl, D., Palinkas, E. D., Girolami, F., Olivotto, I., ... Dal Ferro, M. (2025). Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy: Results From a Multicentric Study. JACC: Heart Failure, 13(9), Article 102529. https://doi.org/10.1016/j.jchf.2025.102529

Karakasis, P., Lefkou, E., Pamporis, K., Farmakis, D., Patoulias, D., Antoniadis, A. P., Heymans, S., Filippatos, G., & Fragakis, N. (2025). Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. European journal of heart failure, 27(9), 1775-1785. https://doi.org/10.1002/ejhf.3637

Mostert, D., van der Putten, C., Kurniawan, N. A., Lässer, C., & Bouten, C. V. C. (2025). Bioengineering structural anisotropy in living tissues. Nature reviews bioengineering, 3(9), 727-741. https://doi.org/10.1038/s44222-025-00338-x

Gilani, K., Verket, M., Peters, C., Dumontier, M., Rocca, H. P. B. L., & Urovi, V. (2025). CDE-Mapper: Using retrieval-augmented language models for linking clinical data elements to controlled vocabularies. Computers in Biology and Medicine, 196, Article 110745. https://doi.org/10.1016/j.compbiomed.2025.110745

Slob, B. P. H., Postma, M. J., Weersma, M., Rocca, H.-P. B.-L., de Jong, L. A., & Boersma, C. (2025). Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands. American journal of cardiovascular drugs : drugs, devices, and other interventions, 25(5), 715-726. https://doi.org/10.1007/s40256-025-00749-6

Aukes, R., Albersen, M., Boelen, A., Kluijtmans, L. A. J., Visser, W. F., de Vries, M. C., Bosch, A. M., C5-OH NBS Working Group, Keularts, I., Panis, B., & Gozalbo, E. R. (2025). Evaluation of Newborn Screening for Diseases Using C5-OH as a Marker: Systematic Review of the Literature and Evaluation of 17 Years of C5-OH Screening in the Netherlands. Journal of Inherited Metabolic Disease, 48(5), Article e70088. https://doi.org/10.1002/jimd.70088

Fragasso, G., Stolfo, D., Anker, M. S., Bayes-Genis, A., Chioncel, O., Heymans, S., Jhund, P. S., Lewis, B. S., Lopaschuk, G. D., Lund, L. H., Gonzalez, A., Pagnesi, M., Schiattarella, G. G., Tocchetti, C. G., van Der Meer, P., Von Linthout, S., Wassmann, S., Westenbrink, B. D., Metra, M., ... Savarese, G. (2025). The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC. European journal of heart failure, 27(9), 1700-1719. https://doi.org/10.1002/ejhf.3703

Geraeds, C. B. G., Bruninx, A., Dekker, A. L. A. J., Barandiaran Aizpurua, A., Bermejo, I., & Brunner-La Rocca, H.-P. (2025). Exploring safety of down-titrating diuretics in heart failure management. European journal of heart failure, 27(8), 1393-1399. https://doi.org/10.1002/ejhf.3714

Weerts, J., Schroen, B. L. M., Barandiaran Aizpurua, A., Berendschot, T. T. J. M., Brandts, L., Webers, C. A. B., Simons, S. O., Meex, S. J. R., Henry, R., van der Kallen, C. J. H., Brunner-La Rocca, H.-P., Knackstedt, C., Heymans, S. R. B., de Boer, R. A., van Empel, V. P. M., & Houben, A. J. H. M. (2025). Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study. Cardiovascular Diabetology, 24(1), Article 310. https://doi.org/10.1186/s12933-025-02850-1

Venner, M. F. G. H. M., Gevers, T. J. G., Ploum, F., Habets, J., Raafs, A. G., Weerts, J., Heymans, S. R. B., van der Leij, C., de Haan, M. W., Verdonschot, J. A. J., Kramer, M., & Knackstedt, C. (2025). Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 431, Article 133226. https://doi.org/10.1016/j.ijcard.2025.133226

Pencheva, M. G., Berends, E., van der Laan, K. W. F., Giudici, A., Niessen, P., Scheijen, J. L. J. M., Vangrieken, P., Leenders, P., Delhaas, T., Caiment, F., Kutmon, M., Trujillo, F. M., Wouters, K., Foulquier, S., Spronck, B., Reesink, K. D., & Schalkwijk, C. G. (2025). Glyoxalase-1 overexpression attenuates arterial wall stiffening in diabetic mice. Cardiovascular Diabetology, 24(1), Article 283. https://doi.org/10.1186/s12933-025-02823-4